Terrible optics: AstraZeneca shares take a hit following report that CEO Soriot is moving to Teva
You can insert this story in the WTF? file.
Wednesday afternoon Israel’s Calcalist reported that AstraZeneca CEO Pascal Soriot has agreed to take the CEO’s job at Teva, filling a role left open at a company that is in the middle of a major upheaval.
The Israeli financial news web site says that Soriot has personally signed off on the new job, accepting a $20 million bonus, according to a story from Reuters. And Haaretz followed up with its own confirmation that Soriot has agreed to take the Teva job, the second non-Israeli to take the position, though they are still discussing terms. The Haaretz report also included word of the $20 million bonus.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters